Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Neuberger Berman Real Estate Securities Income Fund Inc. (NRO)

6   0.08 (1.35%) 02-20 16:00
Open: 5.92 Pre. Close: 5.92
High: 6 Low: 5.92
Volume: 83,461 Market Cap: 285M
Neuberger Berman R/E Securities Income is a closed-end management investment company that invests mainly in securities issued by Real Estate Companies, including Real Estate Investment Trusts (REITs).

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.009 - 6.042 6.042 - 6.073
Low: 5.83 - 5.875 5.875 - 5.915
Close: 5.935 - 6 6 - 6.059

Technical analysis

as of: 2020-02-20 4:42:20 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 7.10     One year: 8.29
Support: Support1: 5.80    Support2: 5.63
Resistance: Resistance1: 6.08    Resistance2: 7.10
Pivot: 5.94
Moving Average: MA(5): 6.00     MA(20): 5.89
MA(100): 5.67     MA(250): 5.36
MACD: MACD(12,26): 0.09     Signal(9): 0.09
Stochastic oscillator: %K(14,3): 72.81     %D(3): 79.32
RSI: RSI(14): 62.77
52-week: High: 6.08  Low: 4.73  Change(%): 24.2
Average Vol(K): 3-Month: 16465  10-Days: 15350

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NRO has closed below upper band by 35.1%. Bollinger Bands are 76.5% wider than normal. The large width of the bands suggest high volatility as compared to NRO's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue.

Headline News

Global Digital Biomarkers Market Analysis and Forecast, 2019-2025: Explosion of Wearable Devices and Increasing Smartphone Penetration Promoting Growth -
DUBLIN--(BUSINESS WIRE)--The "Global Digital Biomarkers Market: Focus on Key Trends, Growth Potential, Competitive Landscape, Components, End Users, Application (Sleep and Movement, Neuro, Respiratory and Cardiological Disorders) and Region - Analysis and Forecast, 2019-2025" report has been added to's offering. The Global Digital Biomarkers Market Report projects the market to grow at a significant CAGR of 40.39% during the forecast period from 2019 to 2025 There are mul

Neurovalens Unveils Modius SLEEP, a Genius Next-Gen Device Powered by Neuroscience to Optimize Sleep Health and Address the Global Sleep Crisis, Without Medication
SAN DIEGO & BELFAST, Northern Ireland--(BUSINESS WIRE)-- #ModiusHealth--Neurovalens, a global HealthTech company focused on developing innovative neuroscience-powered products to improve lives, today introduces Modius SLEEP. The device follows the success of the Company’s first headset, Modius SLIM, which raised $2.5M on Indiegogo in 2017, gaining worldwide popularity with orders from 80+ countries. Modius SLEEP continues the Company’s mission to improve global health and wellness by providing drug-free, neuro

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE American
Sector:  Financial Services
Industry:  Asset Management
Shares Out. (M) 47.42
Shares Float (M)
% Held by Insiders
% Held by Institutions 12.89
Shares Short (K) 148
Shares Short P. Month (K)

Stock Financials

EPS 1.290
Book Value (p.s.) 5.880
PEG Ratio
Profit Margin 348.13
Operating Margin 80.16
Return on Assets (ttm) 2.5
Return on Equity (ttm) 23.7
Qtrly Rev. Growth 1.2
Gross Profit (p.s.) 0.372
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth 80.20
Operating Cash Flow (M) 22.58
Levered Free Cash Flow (M) 8.83

Stock Valuations

P/E 4.65
P/E Growth Ratio 0.01
P/BV 1.02
P/S 16.21
P/CF 12.60

Dividends & Splits

Dividend 0.480
Dividend Yield 0.08
Dividend Pay Date 2019-02-27
Ex-Dividend Date 2020-02-13
Forward Dividend 0.480
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.